Cargando…
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
Conditionally replicating adenoviruses (CRAds), or oncolytic adenoviruses, such as E1B55K-deleted adenovirus, are attractive anticancer agents. However, the therapeutic efficacy of E1B55K-deleted adenovirus for refractory solid tumors has been limited. Environmental stress conditions may induce nucl...
Autores principales: | Su, Bing-Hua, Shieh, Gia-Shing, Tseng, Yau-Lin, Shiau, Ai-Li, Wu, Chao-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742001/ https://www.ncbi.nlm.nih.gov/pubmed/26515462 |
Ejemplares similares
-
Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice
por: Zhao, ZhenZhen, et al.
Publicado: (2010) -
Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer
por: Hu, Che-Yuan, et al.
Publicado: (2023) -
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.
por: Philip, P. A., et al.
Publicado: (1992) -
High MDR‐1 expression by MAIT cells confers resistance to cytotoxic but not immunosuppressive MDR‐1 substrates
por: Fergusson, J.R., et al.
Publicado: (2018) -
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)